Press Releases

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- ­­Patients with lung blood clots who smoke are more likely to be readmitted for lung blood clots than nonsmokers, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West in New York City, who will present the study findings at the CHES

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- Among adults admitted to a hospital with pneumonia, patients who received an influenza vaccination had a lower chance of being readmitted, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West, New York City, who will present the study findi

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- ­­Vaping is not a low-risk substitute for smoking cigarettes, according to researcher Charlie Lin, MD, who authored a case study of a 34-year-old former smoker diagnosed with granulomatosis attributed to two months of electronic cigarette use. Dr. Lin will present his case study at the CHES

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- Patients newly diagnosed with pulmonary arterial hypertension (PAH) treated with macitentan and tadalafil combination therapy showed hemodynamic progress, as well as improvements in function and risk profile, according to Olivier Sitbon, MD, PhD, from Université Paris–Sud, who will pre

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- There is nearly a 40% chance of overdiagnosing chronic obstructive pulmonary disease (COPD) when spirometry is not combined with bronchodilator (BD) testing, often missing asthma and asthma-COPD overlap syndrome (ACOS), according to Srinadh Annangi, MD, from the University of Kentucky, School of Medic

NEW ORLEANS, Oct. 14, 2019 /PRNewswire/ -- The long-acting bronchodilator aclidinium bromide (AB) is safe for patients at increased risk for heart attack and stroke and reduces the risk of new exacerbations in people with chronic obstructive pulmonary disease (COPD), regardless of whether they have had an exacerbation in the preceding year, according to

HOUSTON and LOS ALTOS, Calif., Oct. 14, 2019 /PRNewswire/ -- Univfy®, an AI platform company whose mission is to improve fertility patients' experience an

PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a V

DEERFIELD BEACH, Fla., Oct. 14, 2019 /PRNewswire/ -- Bongo® Rx, an FDA cleared medical device for the treatment of mild to moderate obstructive sleep apnea, utilizes no electricity or batteries. This cutting edge medical technology reduces the carbon footprint in the battle against global warming as no fossil fuels are consumed to power the device dur

MINNEAPOLIS, Oct. 14, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company, today announced the promotion of Chief Operating Officer ­Ari Hoffnung to the newly created role of Chief Strategy Officer. Mr. Hoffnung also serves on Vireo's Boa